07 Jan 2001

Posorutin® (Posorutin® Augentropfen) - Deutschland

Updated: 07 Jan 2001

Posorutin®

Als Adjuvans bei Retinopathia diabetica, Retina- u. Glaskörperblutungen, subkonjunktivale Blutungen u. Thrombosen.

Posorutin® Description, Presentation and Dosage

Posorutin® Description

Posorutin® Drug Class Description

Einzelstoffe

Posorutin® Drug Description

1 ml enth.: Troxerutin 50 mg.

Posorutin® Generic Name

Posorutin® Augentropfen

Posorutin® Presentation

Posorutin® Presentation

Posorutin®

Posorutin® Manufacturer

Ursapharm

Related Learning Zones

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Type 2 Diabetes Knowledge Centre and CME

Type 2 Diabetes Knowledge Centre and CME

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Posorutin® Dosage

Posorutin® Adult Dosage

Chlorhexidindigluconat 0,05 mg (Konservierungsmittel), Natriumchlorid, Dinatriumedetat, Wasser f. Inj.-zwecke.

Posorutin® Precautions, Reactions and Contraindications

Posorutin® Special Precautions

Related Drugs - Eye Health and Disorders

Back to top